Literature DB >> 19293151

Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK.

Jun Xu1, Lan Liao, Jun Qin, Jianming Xu, Dan Liu, Zhou Songyang.   

Abstract

Phosphatidylinositol (PI) 3-kinase mediates multiple pathways that regulate many aspects of the cell including metabolism, survival, migration, and proliferation. Both Akt and cytokine-independent survival kinase (CISK)/SGK3 are known AGC family protein kinases that function downstream of PI 3-kinase. Although the Akt signaling pathway has been studied extensively, the specific signaling cascades that are modulated by CISK remain to be elucidated. To understand CISK function, we affinity-purified the CISK protein complex and identified Flightless-I (FLII) as a novel downstream target of CISK. Here we show that FLII is an in vivo substrate of CISK that functions downstream of PI 3-kinase. CISK can associate with FLII and phosphorylate FLII at residues Ser(436) and Thr(818). FLII has been shown to act as a co-activator for nuclear hormone receptors such as estrogen receptor (ER). We demonstrate here that CISK can enhance ER transcription, which is dependent on its kinase activity, and mutation of CISK phosphorylation sites on FLII attenuates its activity as an ER co-activator. Furthermore, FLII knockdown by RNA interference renders 32D cells more sensitive to interleukin-3 withdrawal-induced apoptosis, suggesting that FLII itself is also a survival factor. These findings support the model that CISK phosphorylates FLII and activates nuclear receptor transcription and suggest a new cell survival signaling pathway mediated by PI 3-kinase and CISK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293151      PMCID: PMC2682886          DOI: 10.1074/jbc.M807770200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4.

Authors:  Thomas Slagsvold; Adriano Marchese; Andreas Brech; Harald Stenmark
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

2.  Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland.

Authors:  Paola Mussi; Lan Liao; Seong-Eun Park; Paolo Ciana; Adriana Maggi; Benita S Katzenellenbogen; Jianming Xu; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-25       Impact factor: 11.205

Review 3.  Serum and glucocorticoid-regulated protein kinases: variations on a theme.

Authors:  Maude Tessier; James R Woodgett
Journal:  J Cell Biochem       Date:  2006-08-15       Impact factor: 4.429

Review 4.  Akt signaling and cancer: surviving but not moving on.

Authors:  Alex Toker; Merav Yoeli-Lerner
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

5.  Renal function of gene-targeted mice lacking both SGK1 and SGK3.

Authors:  Florian Grahammer; Ferruh Artunc; Diana Sandulache; Rexhep Rexhepaj; Björn Friedrich; Teut Risler; James A McCormick; Kevin Dawson; Jian Wang; David Pearce; Peer Wulff; Dietmar Kuhl; Florian Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04       Impact factor: 3.619

Review 6.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

7.  The PTEN-PI3K pathway: of feedbacks and cross-talks.

Authors:  A Carracedo; P P Pandolfi
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 8.  Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.

Authors:  C X Deng; F Scott
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

9.  Interplay of Fli-I and FLAP1 for regulation of beta-catenin dependent transcription.

Authors:  Young-Ho Lee; Michael R Stallcup
Journal:  Nucleic Acids Res       Date:  2006-09-20       Impact factor: 16.971

10.  Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.

Authors:  Elizabeth A Musgrove; C Marcelo Sergio; Sherene Loi; Claire K Inman; Luke R Anderson; M Chehani Alles; Mark Pinese; C Elizabeth Caldon; Judith Schütte; Margaret Gardiner-Garden; Christopher J Ormandy; Grant McArthur; Alison J Butt; Robert L Sutherland
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

View more
  16 in total

1.  SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).

Authors:  Minzhi Hou; Yingrong Lai; Shanyang He; Weiling He; Hongwei Shen; Zunfu Ke
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

2.  Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.

Authors:  Humberto Rodriguez-Rocha; Aracely Garcia Garcia; Laura Zavala-Flores; Sumin Li; Nandakumar Madayiputhiya; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-09-14       Impact factor: 8.401

3.  Blunted IgE-mediated activation of mast cells in mice lacking the serum- and glucocorticoid-inducible kinase SGK3.

Authors:  Irina M Zemtsova; Nicole Heise; Henning Fröhlich; Syed M Qadri; Yuliya Kucherenko; Krishna M Boini; David Pearce; Ekaterina Shumilina; Florian Lang
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

4.  SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.

Authors:  Yuanzhong Wang; Dujin Zhou; Sheryl Phung; Selma Masri; David Smith; Shiuan Chen
Journal:  Mol Endocrinol       Date:  2010-11-17

5.  SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.

Authors:  Yuanzhong Wang; Dujin Zhou; Sheryl Phung; Charles Warden; Rumana Rashid; Nymph Chan; Shiuan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

6.  The BUB3-BUB1 Complex Promotes Telomere DNA Replication.

Authors:  Feng Li; Hyeung Kim; Zhejian Ji; Tianpeng Zhang; Bohong Chen; Yuanlong Ge; Yang Hu; Xuyang Feng; Xin Han; Huimin Xu; Youwei Zhang; Hongtao Yu; Dan Liu; Wenbin Ma; Zhou Songyang
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

7.  AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.

Authors:  Krishna M Vasudevan; David A Barbie; Michael A Davies; Rosalia Rabinovsky; Chontelle J McNear; Jessica J Kim; Bryan T Hennessy; Hsiuyi Tseng; Panisa Pochanard; So Young Kim; Ian F Dunn; Anna C Schinzel; Peter Sandy; Sebastian Hoersch; Qing Sheng; Piyush B Gupta; Jesse S Boehm; Jan H Reiling; Serena Silver; Yiling Lu; Katherine Stemke-Hale; Bhaskar Dutta; Corwin Joy; Aysegul A Sahin; Ana Maria Gonzalez-Angulo; Ana Lluch; Lucia E Rameh; Tyler Jacks; David E Root; Eric S Lander; Gordon B Mills; William C Hahn; William R Sellers; Levi A Garraway
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

8.  The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.

Authors:  Xuyang Feng; Zhenhua Luo; Shuai Jiang; Feng Li; Xin Han; Yang Hu; Dan Wang; Yong Zhao; Wenbin Ma; Dan Liu; Junjiu Huang; Zhou Songyang
Journal:  J Cell Sci       Date:  2013-06-26       Impact factor: 5.285

9.  SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1.

Authors:  Yuanzhong Wang; Dujin Zhou; Shiuan Chen
Journal:  Mol Endocrinol       Date:  2014-04-16

10.  Amphiregulin retains ERα expression in acquired aromatase inhibitor resistant breast cancer cells.

Authors:  Yuanzhong Wang; Yen-Dun Tony Tzeng; Gregory Chang; Xiaoqiang Wang; Shiuan Chen
Journal:  Endocr Relat Cancer       Date:  2020-12       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.